期刊文献+

MRI对自体骨髓间质干细胞移植于缺血心肌后动态监测价值的实验研究 被引量:2

Dynamic MRI of ferumoxide-labeled bone mesenchymal stem cells after transplantation in infarcted myocardium
原文传递
导出
摘要 目的评价MR/对干细胞移植于缺血心肌后的动态监测价值。方法中华小型猪6头,抽取髂骨骨髓并制备自体骨髓间质干细胞(mesenchymal stem cells,MSCs),以注射用超顺磁性氧化铁颗粒(SPIO)及4′,6-二脒基-2-苯基吲哚(DAPI)标记细胞并进行标记率检测。开胸结扎冠状动脉左前降支制备小型猪心肌梗死模型。模型建立后14d,MR延迟增强成像(DE—MRI)检测梗死面积,之后行第2次开胸,于每只动物心肌梗死周边区和正常心肌区直视下经心外膜各注射标记的MSCs 2个点,同时分别于各区注射培养基2个点作为对照点。细胞移植后24h及21d,快速梯度回波序列(FGRE)T2^*像检测干细胞移植点低信号区的面积及信号强度。T2^*信号减低区范围的测量由FGRE面积法实现,其信号减低的程度以正常心肌区和该区的T2^*值之差与正常心肌区T2^*值的百分比表示。病理组织学检查心肌细胞形态、瘢痕形成、毛细血管密度及干细胞分布情况。不同时间点MSCs注射点低信号区面积及T2^*信号强度的比较采用重复测量方差分析及配对t检验。干细胞注射点与对照点毛细血管密度的比较、梗死周边区及正常心肌区MSCs注射点信号衰减幅度和DAPI阳性细胞密度的比较采用成组资料t检验。结果DAPI及SPIO对MSCs的标记率均达100%。心肌梗死模型建立后第14天,小型猪心肌梗死面积为(33.6±8.9)%。细胞移植后24h,标记MSCs注射点于MRI显示为边界清晰的卵圆形T2^*低信号区,梗死周边区与正常心肌区MSCs注射点T2^*低信号区的信号强度[分别为(67.00±5.48)%、(61.92±7.76)%,t=1.65,P=0.1158)]及面积[分别为(0.56±0.24)、(0.52±0.25)cm^2,t=0.39,P=0.7044)]差异均无统计学意义。移植后3周,T2^*低信号区与正常心肌区的对比程度均较前下降,梗死周边区减低至(40.12±5.93)%(t=9.53,P〈0.01);正常心肌区减低为(46.92±6.25)%(t=11.03,P〈0.01)。梗死边缘区T2^*减低的程度大于正常心肌区MSCs注射点,且2组间信号强度减弱幅度分别为(26.88±7.27)%和(15.00±4.51)%,差异有统计学意义(F=20.08,P=0.0003)。正常心肌区MSCs注射点心肌组织中荧光标记的细胞核分布密度高于梗死边缘区MSCs注射点[分别为(106±25)和(143±31)个/高倍镜(t=-2.47,P=0.0293)]。梗死边缘区MSCs注射点组织中毛细血管分布密度高于该区对照点[分别为(13.4±4.0)和(9.4±3.1)个/高倍镜,t=2.49,P=0.0229]。MSCs移植于心肌组织中3周后,普鲁士蓝染色阳性的铁颗粒仅位于部分移植MSCs细胞核周围。结论MRI可在一定时间内实现对移植干细胞的示踪并反映移植MSCs在心肌局部的数量变化趋势,但是对于移植细胞的半定量监测存在局限性。移植干细胞所在的微环境是影响其生存时间的重要因素之一。 Objective To investigate the ability of magnetic resonance imaging (MRI) in tracking magnetically labeled mesenchymal stem cells (MR-MSCs) in a swine myocardial infarction (MI) model. Methods Adult Chinese mini-pigs (n = 6) were subjected to open-chest experimental MI operation. Their autogeneic bone marrow-derived mesenchymal stem cells (MSCs) was cultured and doubly labeled with ferumoxides and DAPI. On the 14 th day after MSCs transplantation, the size and location of the myocardial infarction were assessed by using delayed-enhancement MRI (DE-MRI). Then the labeled MSCs were injected intramyocardially into peri-infarct zone and normal myocardium. At 24 hrs and 3 weeks after injection, the contrast and the volume of the MR-MSCs hypointense lesion from the MR images were acquired, and the contrast was determined using the difference in signal intensity between the hypointense and normal myocardium divided by signal intensity of the normal region. After humane euthanasia, the heart was excised and histology corresponding to MRI slices that demonstrated MR-MSCs lesions was performed. Repeated-measures ANOVA and a paired t test were used for comparison of the contrast and the volume of the MR-MSCs hypointense lesion at different time points. Comparisons between independent groups were performed with the standard Student t test. Results The labeling efficiency of ferumoxides and DAPI was 100% o On the 14 th day after the MI operation, the average percentage of infracted myocardial area was (33. 6±8. 9)% . Twenty- four hours after MSCs transplantation, MSCs injection sites appeared as ovoid hypointensive lesions with sharp border on T2^ * images. At 24 h after injection, the signal contrast [(67.00±5.48)% vs (61.92 ±7.76)%,t =1.65,P=0.1158]and the size [(0.56±0.24)cm^2 vs (0. 52± 0. 25 )cm^2, t = 0. 39, P = 0. 7044 ] of the lesions showed no statistical difference between the periinfarct zone and the normal myocardium. At 3 weeks after injection, the signal contrast decreased and the size diminished both in the peri-infarct zone and in the normal myocardium. Moreover, the contrast of the lesions in peri-infarct zone decreased more significantly than that in normal myocardium [ (26. 88 ± 7. 27) % vs ( 15.00 ± 4. 51 ) %, F = 20. 08, P = 0. 0003 ]. Post mortem analysis found the fluorescently labeled MSCs demonstrated on histological sections. There were much more dense fluorescently labled MSCs per high power fields at injection sites of normal myocardium than at injection sites of peri-infarct zone [ ( 106 ± 25)/HPF vs (143 ±31 )/HPF, t = -2.47, P =0. 0293 ]. In MSCs injection sites of the peri-infarct zone, the capillary density was significantly higher than that in control sites [ (13.4 ± 4. 0)/HPF vs (9.4 ± 3.1 )/HPF, t = 2.49, P = 0. 0229]. At 3 weeks after injection, ferumoxide was contained within partial original MSCs. Conclusion Magnetic resonance imaging of MSCs is a feasible method for the in vivo tracking of transplanted stem cells and could reflect the tendency of the local stem cell quantity, but there still has limitation for the semi-quantitation of the transplanted stem cells.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2009年第3期305-310,共6页 Chinese Journal of Radiology
基金 国家自然科学基金资助项目(30670609) 国家教委博士点专项基金资助项目(20050023042)
关键词 磁共振成像 间质干细胞 心肌梗死 Magnetic resonance imaging Mesenchymal stem cell Myocardial infarction
  • 相关文献

参考文献13

  • 1Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature,2001,410:701-705.
  • 2Kraitchman DL, Tatsumi M, Gilson WD,et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation ,2005,112 : 1451-1461.
  • 3Zhang SJ, Wu JC. Comparison of imaging techniques for tracking cardiac stem cell therapy. J Nucl Med,2007 ,48 :1916-1919.
  • 4Dousset V, Tourdias T, Brochet B, et al. How to trace stem cells for MRI evaluation? J Neural Sci ,2008,265:122-126.
  • 5Pawelczyk E, Arbab AS, Chaudhry A, et al. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells ,2008,26 : 1366-1375.
  • 6Sosnovik DE, Nahrendorf M, Weissleder R. Molecular magnetic resonance imaging in cardiovascular medicine. Circulation,2007, 115:2076-2086.
  • 7黄浙勇,葛均波,杨姗,张少衡,黄榕翀,金航,曾蒙苏,孙爱军,钱菊英,邹云增.超顺磁性氧化铁标记间充质干细胞心肌移植的磁共振成像研究[J].中华心血管病杂志,2007,35(4):344-349. 被引量:10
  • 8Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation ,2003,107:2290-2293.
  • 9Li Z, Suzuki Y, Huang M, et al. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cell, 2008,26: 864-873.
  • 10Amsalem Y, Mardor Y, Feinberg MS, et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation, 2007 , 116 ( 11 Suppl ) : 138 -145.

二级参考文献18

  • 1黄浙勇,葛均波.细胞示踪技术在心脏病干细胞移植中的应用[J].中华心血管病杂志,2006,34(11):1049-1052. 被引量:5
  • 2Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration ) trial.Circulation, 2006,113 (10): 1287-1294.
  • 3Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature, 2001,410 (6829) :701 -705.
  • 4Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature, 2004,428(6983):668-673.
  • 5Shake JG, Gruber P J, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg,2002,73 (6) : 1919-19.
  • 6Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation, 2003,107 ( 18 ) :2290-2293.
  • 7Pintaske J, Helms G, Banfleon R, et al. A preparation technique for quantitative investigation of SPIO-containing solutions and SPIO-labelled cells by MRI. Biomed Tech (Bed) , 2005,50 (6) :174-180
  • 8Weber A, Pedrosa I, Kawamoto A, et al. Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease. Eur J Cardiothorac Surg,2004,26( 1 ) :137-143.
  • 9Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation, 2003,107(16) :2134-2139.
  • 10Kraitchman DL, Tatsumi M, Gilson WD, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation, 2005,112(10) : 1451-1461.

共引文献9

同被引文献55

  • 1朱海云,田建明,王莉,曾浩,黄胜东,徐训宇,陆健.MRI与正电子发射计算机体层、单光子发射计算机体层显像检测活性心肌的对比研究[J].中华放射学杂志,2005,39(6):593-598. 被引量:9
  • 2张大鹏,杨新春.心肌组织水平再灌注的研究进展[J].中华心血管病杂志,2006,34(8):762-765. 被引量:11
  • 3Beller GA,Zaret BL.Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease.Circulation,2000,101:1465-1478.
  • 4Llaurado JG.The quest for the perfect myocardial perfusion indicator:still a long way to go.J NucI Med,2001,42:282-284.
  • 5Liu S.Ether and crown ether-containing cationic ^99Tc^m complexes useful as radiopharmaceuticals for heart imaging.Dalton Trans,2007,28:1183-1193.
  • 6Boschi A,Bolzati C,Uccelli L,et al.A class of asymmetrical nitrido ^99Tc^m heterocmplexes as heart imaging agents with improved biological properties.Nucl Med Commun,2002,23:689 -693.
  • 7Cittanti C,Uccelli L,Pasquali M,et al.Whole-body biodistribution and radiation dosimetry of the new cardiac tracer ^99Tc^m-N-DBODC.J Nucl Med,2008,49:1299-1304.
  • 8Kim YS,Wang J,Broisat A,et al.^99Tc^m-N-MPO:novel cationic ^99Tc^m radiotracer for myocardial perfusion imaging.J Nucl Cardiol,2008,15:535-546.
  • 9Kim YS,Shi J,Zhai S,et al.Mechanism for myocardial localization and rapid liver clearance of ^99Tc^m-N-MPO:a new perfusion radiotracer for heart imaging.J Nucl Cardiol,2009,16:571-579.
  • 10Fang W,Liu Y,Zhu L,et al.Evaluation of ^99Tc^mN-15C5 as a new myocardial perfusion imaging agent in normal dogs and canines with coronary stenosis.Nucl Med Commun,2008,29:775-781.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部